NEW YORK (GenomeWeb News) – Three Dutch institutes have joined forces in a public-private partnership to invest €28 million in personalized medicine projects, they announced today.
The three groups — the BioMedical Materials Program, the Center for Translational Molecular Medicine, and the Top Institute Pharma — have already selected seven projects that will receive funding from the collaboration. The projects will focus on personalized medicine research in cardiovascular diseases and cancer.